Showing all 14 results

  • Capecitabine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.

    Active IngredientStrengthPrimary Clinical Function
    Capecitabine USP/Ph.Eur.150 mgThe Precision Titration Anchor: Utilized for accurate dose adjustments based on Body Surface Area (BSA).
    Capecitabine USP/Ph.Eur.500 mgThe Oncology Macrodose: The primary therapeutic unit for standard cycles in Colorectal and Breast cancer.
    ExcipientsProprietary MatrixHigh-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust during handling by healthcare professionals.
  • Estramustine Phosphate Capsules

    Free

    Estramustine phosphate capsules typically contain estramustine phosphate sodium as the active medicinal ingredient, along with several inactive excipients to ensure the drug’s stability and delivery.

  • Imatinib Capsules

    Free

    Imatinib capsules contain the active oncology drug and a specific set of inactive ingredients designed to stabilize the compound for oral delivery.

  • Lenalidomide Capsules

    Free

    Lenalidomide capsules (brand name Revlimid) are a potent immunomodulatory medication used to treat certain types of cancers, such as multiple myeloma and myelodysplastic syndromes.

  • Methotrexate Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile Isotonic Solution (Ready-to-Use) or Lyophilized Powder (High Dose).

    Active IngredientStrengthCommon Application
    Methotrexate USP/BP2.5 mg / mlLow Dose (Rheumatology/Dermatology)
    Methotrexate USP/BP25 mg / mlStandard Oncology Dose
    Methotrexate USP/BP50 mg / 500 mg / 1 gHigh Dose MTX (Leukemia Protocols)
    PreservativeBenzyl AlcoholPresent in Multi-dose Vials (Avoid in IT use)

    *Pack Sizes: 2 ml Vial, 20 ml Vial, or 50 ml Vial.

  • Mitomycin Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile Lyophilized Powder (Purple/Blue Cake) in amber glass vials.

    Active IngredientStrengthPrimary Use
    Mitomycin USP/BP2 mgOphthalmic Surgery / Pterygium
    Mitomycin USP/BP10 mgSystemic Chemotherapy / Bladder Instillation
    Mitomycin USP/BP20 mg / 40 mgHigh-Dose Bladder Protocols
    ExcipientsMannitolBulking Agent

    *Pack Sizes: Single Vial. (Must be handled with cytotoxic precautions).

  • Oxaliplatin Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile, Clear, Aqueous Concentrate in glass vials. (Also available as Lyophilized Powder depending on market preference).

    Active IngredientStrengthVolume
    Oxaliplatin USP/BP5 mg / ml10 ml Vial (Total 50 mg)
    Oxaliplatin USP/BP5 mg / ml20 ml Vial (Total 100 mg)
    ExcipientsWater for InjectionPreservative-Free Solution

    *Pack Sizes: Single Vial. (Must be handled with strict cytotoxic precautions).

  • Pemetrexed Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile Lyophilized Powder (White to Light-Yellow Cake) in glass vials.

    Active IngredientStrengthReconstitution
    Pemetrexed Disodium100 mgRequires 0.9% Sodium Chloride
    Pemetrexed Disodium500 mgRequires 0.9% Sodium Chloride
    Pemetrexed Disodium1000 mg (1 g)High-Dose Protocols
    ExcipientsMannitol / Hydrochloric Acid / Sodium HydroxideBulking Agent / pH Adjusters (pH 6.6 – 7.8)

    *Pack Sizes: Single Vial. (Must be handled with strict cytotoxic precautions).

  • Sorafenib Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, child-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the tosylate salt formulation.

    Active IngredientStrengthPrimary Clinical Function
    Sorafenib Tosylate INN/Ph.Eur.200 mg (Equivalent to Sorafenib free base)Global Standard: Base titration unit for the standard 800 mg daily oncology regimen.
    ExcipientsCroscarmellose Sodium / Microcrystalline Cellulose / Hypromellose / Magnesium StearateSuperdisintegrant / Diluent / Film-Coating (Engineered for strict gastric dissolution and reliable systemic bioavailability)
  • Temozolamide Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Hard Gelatin Capsule, packed in highly secure, child-resistant and moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles. We offer the complete range of strengths required for exact, weight-based (Body Surface Area) oncology dosing.

    Active IngredientStrengthPrimary Clinical Use
    Temozolomide INN/Ph.Eur.20 mgMicro-dosing for strict Body Surface Area (BSA) rounding and pediatric protocols.
    Temozolomide INN/Ph.Eur.100 mg / 140 mgStandard titration strengths for concurrent radiotherapy and maintenance phases.
    Temozolomide INN/Ph.Eur.250 mgHigh-dose foundation for the 5-day maintenance cycle in adult GBM patients.
    ExcipientsLactose Anhydrous / Colloidal Silicon Dioxide / Sodium Starch Glycolate / Stearic AcidDiluent / Glidant / Superdisintegrant (Engineered for immediate gastric capsule dissolution)
  • Thioguanine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Scored Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles, engineered to maintain absolute stability and physical containment of the cytotoxic agent.

    Active IngredientStrengthPrimary Clinical Use
    Thioguanine USP/Ph.Eur.40 mgStandard Adult/Pediatric Dose (Titrated by Body Surface Area or Weight) for AML and ALL.
    ExcipientsLactose Monohydrate / Potato Starch / Magnesium Stearate / Stearic AcidDiluent / Glidant (Engineered for immediate gastric dispersion and precise tablet splitting)
  • Vinblastine Sulphate Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile Lyophilized Powder (White to Off-White) or as a Ready-to-Use Liquid Solution in glass vials.

    Active IngredientStrength & FormatReconstitution / Dilution
    Vinblastine Sulphate USP/BP10 mg / 10 ml (Liquid)Ready-to-use solution (1 mg/ml). Requires further dilution in 0.9% NaCl before infusion.
    Vinblastine Sulphate USP/BP10 mg (Lyophilized Powder)Requires exactly 10 ml of Bacteriostatic 0.9% Sodium Chloride to yield 1 mg/ml.
    ExcipientsSodium Chloride / Water for InjectionIsotonicity / Solvent System

    *Pack Sizes: Single Vial encased in specialized protective cytotoxic shrink-wrap

  • Vincristine Sulphate Injection

    Free

    Vincristine sulphate injection (often known by the brand Oncovin) is a sterile, preservative-free solution of vinca alkaloid chemotherapy agent derived from the periwinkle plant. It is a clear, colourless liquid typically supplied in 1 mg or 2 mg vials.